| Prev Close | 4.09 |
| Day Low/High | 3.92 / 4.13 |
| 52 Wk Low/High | 3.04 / 4.99 |
BioDelivery Sciences International, Inc. (BDSI)
3.99
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 98.60B |
| Market Cap | 403.26M |
| P/E Ratio | 27.60 |
| Div & Yield | N.A. (N.A) |
Latest News
Matching Downside Protection With Upside Potential in Akebia Therapeutics
This covered call strategy is an effective way to navigate an overbought market.
The Indices Are Doing a Poor Job of Reflecting What's Really Going On
Here are several names I'm looking to build on further weakness.
The Pockets of Speculative Action Continue to Be Pretty Narrow
I continue to be concerned about the price action of the indices but I can't complain about the stock picking.
2 Biotech Stocks to Buy on Solid Q2 Results
Covid-19 has had a big impact on this sector, but these names have strong catalysts going into the next quarter.
No Predictions, But 2 Picks for the Second Half of 2020
BioDelivery Sciences International and Tivity Health are two candidates investors should consider going forward.
Strong Rebound From Covid-19 Meltdown Turns Bargain Hunting Into a Challenge
A now-overbought market leaves few values available among equities.
Eye-Catching Quarterly Results From a Trio of Companies
The first-quarter reports from Camping World, Esperion Therapeutics and BioDelivery Sciences were impressive amid coronavirus disruption.
Here's a Quartet of Small Biotechs That Could Make for Acquisition Targets
Merger activity is picking up this week in the biotechnology sector and these four promising companies would be good buyout candidates.
2 Small Biopharma Stocks That Should Perk Up as Nation Returns to Work
Flexion Therapeutics and BioDelivery Sciences International have promising products that should do well once the fixation on Covid-19 treatments wanes.
These 2 Stocks Should Easily Withstand the Economic Impacts of Covid-19
DropBox and BioDelivery Sciences are names to consider during the market choppiness of the coming weeks.
Adding to My Biotech Positions When Profit-Taking Hits
Here's my strategy which has worked particularly well.
3 Small-Cap Biotech Stocks That Could Thrive in 2020
The trio of BioDelivery Sciences, Omeros and TG Therapeutics looks well-positioned to capitalize on their potential in the New Year.
3 Small Biotechs With Favorable Risk Vs. Reward Profiles
BioDelivery Sciences International, Chiasma Inc. and TherapeticsMD all feature promising treatments.
3 Small-Caps That Look Like Bargains at Current Trading Levels
The trio consists of BioDelivery Sciences International, Beazer Homes USA and Redhill Biopharma.
These Two Small-Cap Stocks Are Executing Well
Both Digital Turbine and BioDelivery Sciences have done well in 2019.
Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs
I am incrementally using buy-write option orders to add some shares to core holdings.
These 3 Biotech Stocks Are Moving Closer to Profitability
Here are updates on small biotech/biopharma names I have profiled before.
My Post-Earnings Assessment of 2 Biotech Stocks
Let's look at a couple of companies we have covered on these pages before.
3 Small Biotechs to Watch as Earnings Season Winds Down
One already is up nicely on its results, while the other two should issue reports of interest in the next few days.
Here Are 3 Small-Cap Names for Biotech Investors to Consider
We look at a slightly riskier part of the sector...that should be able to reach profitability with little to no additional funding needs.
3 Small Biotechs That Came Up Big on Thursday
Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.
3 Small Biotechs Turn on the Revenue Jets
BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.
5 Small Biotechs Receive Shots in the Arm
Favorable quarterly results and FDA drug approvals should help lift these five names.
5 Small Biotechs Receive Shots in the Arm
Favorable quarterly results and FDA drug approvals should help lift these five names.
4 Small-Caps on My Earnings Watch List
We are coming my favorite part of earnings season -- when these small-caps report.
3 Biotech Stocks on Readers' Minds
We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.
Trump's FDA: A Friendlier Biotech Sheriff
There still will be winners and losers, but the new administration's FDA is a net plus for the industry.
